— Know what they know.
Not Investment Advice

ZIMV NASDAQ

ZimVie Inc.
1W: +0.1% 1M: +0.6% 3M: +1.1% 1Y: +28.3% 3Y: +162.7%
$18.99
Last traded 2025-10-21 — delisted
NASDAQ · Healthcare · Medical - Devices · $535.6M mcap · 27M float · 2.66% daily turnover · Short 29% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$450M -1.7% ▼
5Y CAGR: -15.7%
Gross Profit
$287M -1.0% ▼
5Y CAGR: -16.8%
Operating Income
-$21M +33.2% ▲
Net Income
-$26M +93.4% ▲
EPS (Diluted)
$-0.94 +93.7% ▲
EBITDA
$30M -67.5% ▼
5Y CAGR: -22.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$912M$1.0B$914M$457M$450M
YoY Growth-13.6%+11.2%-9.9%-49.9%-1.7%
Cost of Revenue$313M$386M$301M$167M$162M
Gross Profit$600M$629M$613M$290M$287M
Gross Margin65.7%62.0%67.1%63.5%63.9%
R&D Expenses$49M$61M$63M$26M$27M
SG&A Expenses$534M$554M$524M$249M$239M
Operating Expenses$668M$702M$668M$321M$308M
Operating Income-$67M-$74M-$51M-$31M-$21M
Operating Margin-7.4%-7.3%-5.6%-6.8%-4.6%
Interest Expense$302K$405K$11M$20M$19M
Income Before Tax-$221M-$101M-$110M-$51M-$24M
Tax Expense-$42M-$6M-$46M$5M$10M
Net Income-$179M-$95M-$64M-$393M-$26M
Net Margin-19.6%-9.4%-7.0%-86.0%-5.7%
EPS (Diluted)$-6.86$-3.65$-2.45$-14.87$-0.94
EBITDA-$87M$29M$79M$91M$30M
Shares Outstanding26M26M26M26M27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms